Impact of Pharmacist Intervention on Electrocardiogram Monitoring of Pediatric Patients on Multiple QTc Interval–Prolonging Medications
Authors:
- 1 January 2017
- journal article
- Published by The Pediatric Pharmacy Association in The Journal of Pediatric Pharmacology and Therapeutics
- Vol. 22 (6) , 399-405
Abstract
OBJECTIVES To determine whether dedicated pharmacy services improve the rate of electrocardiogram (ECG) monitoring in patients at risk for medication-induced QTc interval prolongation. In addition, determine how pediatric institutions currently monitor patients at risk for medication-induced QTc interval prolongation. METHODS A pharmacist-driven monitoring protocol to detect medication-induced QTc interval prolongation was developed using published literature. If patients were prescribed 3 or more medications known to prolong the QTc interval, they were recommended to have a baseline ECG to assess the QTc interval. If 3 or more QTc interval–prolonging medications were administered for 5 or more days, a follow-up ECG was recommended. Patients prescribed medications known to prolong the QTc interval were identified. Prior to pharmacist intervention, electronic medical records were reviewed to determine if baseline and follow-up ECGs were obtained in patients meeting criteria for monitoring. A dedicated pharmacist then prospectively reviewed charts and recommended monitoring. The rate of monitoring during the intervention and baseline period was compared. To determine current practice at pediatric institutions, a survey was distributed to pharmacists. RESULTS Pharmacist intervention improved the rate of ECG monitoring in patients at risk for medication-induced QTc interval prolongation from 47.8% to 100% (p = 0.0009). Of the 55 survey participants, 6 stated their institution had QTc interval monitoring procedures in place, 35 did not have any, and 3 had procedures in process. CONCLUSIONS Targeted pharmacist intervention improved the rate of ECG monitoring in patients at risk for medication-induced prolonged QTc interval. Our research and survey data reveal that institutions could benefit from targeted pharmacist intervention to monitor patients for medication-induced QTc interval prolongation.Keywords
This publication has 18 references indexed in Scilit:
- Epidemiology of symptomatic drug-induced long QT syndrome and torsade de pointes in GermanyEP Europace, 2013
- Prevention of Torsade de Pointes in Hospital SettingsCirculation, 2010
- Prevalence of the Congenital Long-QT SyndromeCirculation, 2009
- Clinically relevant QTc prolongation due to overridden drug–drug interaction alerts: a retrospective cohort studyBritish Journal of Clinical Pharmacology, 2009
- Drug‐induced torsades de pointes: a review of the Swedish pharmacovigilance databasePharmacoepidemiology and Drug Safety, 2008
- The Relevance of Prolonged QTc Measurement to Pediatric PsychopharmacologyJournal of the American Academy of Child & Adolescent Psychiatry, 2003
- Improving Recognition of Drug InteractionsMedical Care, 2002
- Spectrum of drugs prolonging QT interval and the incidence of torsades de pointesEuropean Heart Journal Supplements, 2001
- New normal limits for the paediatric electrocardiogramEuropean Heart Journal, 2001
- Proarrhythmia Associated With Cisapride in ChildrenPediatrics, 1998